Clinical Trials Logo

Recurrent/Refractory CNS clinical trials

View clinical trials related to Recurrent/Refractory CNS.

Filter by:
  • None
  • Page 1

NCT ID: NCT01542918 Active, not recruiting - Clinical trials for Intraocular Lymphoma

Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma

Start date: December 17, 2012
Phase: Phase 1
Study type: Interventional

This is a Phase I study, which means that the goal is to see if the study treatment is safe. The purpose of this study is to test the safety of Lenalidomide at different dose levels, and to test the safety of Lenalidomide alone or in combination with Rituximab (also known as Rituxan®).